$1.39
-0.02-1.42%
Last update: Oct 23, 6:30 PM
MediciNova Inc (MNOV) Stock Price, Quote, News & History
MNOVNASDAQ
MediciNova reported Phase 2 topline trial results for tipelukast in treating NAFLD and hypertriglyceridemia.
You can purchase shares of MediciNova (NASDAQ:MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
MediciNova has a consensus price target of $7.20.
The stock price for MediciNova (NASDAQ: MNOV) is $1.4 last updated October 23, 2026 at 6:30 PM EDT.
There are no upcoming dividends for MediciNova.
MediciNova does not have any upcoming earnings scheduled.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166...
